BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26182970)

  • 1. Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.
    Grecchi E; O'Doherty J; Veronese M; Tsoumpas C; Cook GJ; Turkheimer FE
    J Nucl Med; 2015 Sep; 56(9):1408-14. PubMed ID: 26182970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
    Teoh EJ; McGowan DR; Macpherson RE; Bradley KM; Gleeson FV
    J Nucl Med; 2015 Sep; 56(9):1447-52. PubMed ID: 26159585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT.
    Lee YS; Kim JS; Kim KM; Kang JH; Lim SM; Kim HJ
    Ann Nucl Med; 2014 May; 28(4):340-8. PubMed ID: 24504938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
    Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and structural synergy for resolution recovery and partial volume correction in brain PET.
    Shidahara M; Tsoumpas C; Hammers A; Boussion N; Visvikis D; Suhara T; Kanno I; Turkheimer FE
    Neuroimage; 2009 Jan; 44(2):340-8. PubMed ID: 18852055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR.
    Schramm G; Maus J; Hofheinz F; Petr J; Lougovski A; Beuthien-Baumann B; Oehme L; Platzek I; van den Hoff J
    Med Phys; 2015 Nov; 42(11):6468-76. PubMed ID: 26520736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the impact to PET quantification and image quality of an anterior array surface coil for PET/MR imaging.
    Wollenweber SD; Delso G; Deller T; Goldhaber D; Hüllner M; Veit-Haibach P
    MAGMA; 2014 Apr; 27(2):149-59. PubMed ID: 23800803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.
    Zielinski A; Behrendt FF; Verburg FA; Mottaghy FM; Krohn T
    Hell J Nucl Med; 2014; 17(3):194-9. PubMed ID: 25397625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT.
    Apostolova I; Wiemker R; Paulus T; Kabus S; Dreilich T; van den Hoff J; Plotkin M; Mester J; Brenner W; Buchert R; Klutmann S
    Eur Radiol; 2010 Aug; 20(8):1868-77. PubMed ID: 20306084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
    Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
    Beheshti M; Vali R; Waldenberger P; Fitz F; Nader M; Loidl W; Broinger G; Stoiber F; Foglman I; Langsteger W
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1766-74. PubMed ID: 18465129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
    Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
    Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.